MedTrace Logo

Inhaled Nitric Oxide in Brain Injury

NCT03260569 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2025-04-30

Study results available
· View outcomes & findings →

Summary

This study will evaluate the changes in respiratory mechanics following traumatic brain injury and determine the effect of inhaled nitric oxide on gas exchange.

Conditions

Interventions

DRUG

Inhaled Nitric Oxide

Patients randomized to this arm will receive inhaled nitric oxide 20 parts per million.

DRUG

Placebo

Nitrogen plus oxygen

Sponsors & Collaborators

  • University of Cincinnati

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-12
Primary Completion
2023-12-28
Completion
2023-12-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03260569 on ClinicalTrials.gov